Cerebellum’s UnitedHealth UNH Stock Holding History

Cerebellum’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-363	Closed	-$80K	–	585
2020 Q2	$80K	Buy	+363	New	+$104K	0.06%	366
2018 Q1	–	Sell	-363	Closed	-$80K	–	537
2017 Q4	$80K	Buy	+363	New	+$76.9K	0.06%	366

Other funds holding UNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cerebellum's UNH Position: Q3 2020 in Review

Cerebellum sold out of UnitedHealth (UNH) in Q3 2020, closing a stake of 363 shares — an estimated $80K sold.

Cerebellum first reported a position in UNH in Q4 2017 and held it in 2 quarters. The position peaked at $80K in Q2 2020. 2,238 funds tracked by Wall St. Rank hold UNH as of Q3 2020.

Cerebellum reported no remaining UnitedHealth position as of Q3 2020 after selling out during the quarter.
Cerebellum sold 363 UnitedHealth shares in Q3 2020, an estimated $80K.
Cerebellum first reported a position in UnitedHealth in Q4 2017 and held it in 2 quarters.
Cerebellum's UnitedHealth position peaked at $80K in Q2 2020.
2,238 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.